# Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

> **NCT00089206** · PHASE2 · COMPLETED · sponsor: **University of Virginia** · enrollment: 7 (actual)

## Conditions studied

- Intraocular Melanoma
- Melanoma (Skin)

## Interventions

- **BIOLOGICAL:** incomplete Freund's adjuvant
- **BIOLOGICAL:** multi-epitope melanoma peptide vaccine
- **BIOLOGICAL:** sargramostim

## Key facts

- **NCT ID:** NCT00089206
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** 2005-11
- **Final completion:** —
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2014-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00089206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00089206, "Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00089206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*